Erupción acneiforme por inhibidores del receptor de crecimiento epidérmico
- 30 September 2005
- journal article
- research article
- Published by Elsevier BV in Actas Dermo-Sifiliograficas
- Vol. 96 (7), 450-454
- https://doi.org/10.1016/s0001-7310(05)73110-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Trichomegaly following treatment with gefitinib (ZD1839)British Journal of Dermatology, 2004
- Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumoursBritish Journal of Dermatology, 2004
- The role of EGFR inhibitors in nonsmall cell lung cancerCurrent Opinion in Oncology, 2004
- Acneiform lesions secondary to ZD1839, an inhibitor of the epidermal growth factor receptorClinical and Experimental Dermatology, 2004
- Reacción cutánea secundaria a tratamiento con Iressa (ZD1839)Actas Dermo-Sifiliograficas, 2004
- Tolerability of gefitinib in patients receiving treatment in everyday clinical practiceBritish Journal of Cancer, 2003
- Cutaneous Side Effects in Non-Small Cell Lung Cancer Patients Treated with Iressa (ZD1839), an Inhibitor of Epidermal Growth FactorPublished by Medical Journals Sweden AB ,2003
- Epidermal Growth Factor Receptor Inhibition Induces TrichomegalyActa Oncologica, 2003
- Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptorBritish Journal of Dermatology, 2002
- Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225British Journal of Dermatology, 2001